» Articles » PMID: 15324697

Dominant Effects of an Msh6 Missense Mutation on DNA Repair and Cancer Susceptibility

Overview
Journal Cancer Cell
Publisher Cell Press
Specialty Oncology
Date 2004 Aug 25
PMID 15324697
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in DNA mismatch repair (MMR) genes cause hereditary nonpolyposis colorectal cancer (HNPCC), and MMR defects are associated with a significant proportion of sporadic cancers. MMR maintains genome stability and suppresses tumor formation by preventing the accumulation of mutations and by mediating an apoptotic response to DNA damage. We describe the analysis of a dominant MSH6 missense mutation in yeast and mice that causes loss of DNA repair function while having no effect on the apoptotic response to DNA damaging agents. Our results demonstrate that MSH6 missense mutations can effectively separate the two functions, and that increased mutation rates associated with the loss of DNA repair are sufficient to drive tumorigenesis in MMR-defective tumors.

Citing Articles

Mismatch repair gene correlates with the prognosis, immune status and immune checkpoint inhibitors response of endometrial cancer.

Zhou L, Xiao H, Chen J Front Immunol. 2024; 15:1302797.

PMID: 38390329 PMC: 10881679. DOI: 10.3389/fimmu.2024.1302797.


Colorectal cancer murine models: Initiation to metastasis.

Pothuraju R, Khan I, Jain M, Bouvet M, Malafa M, Roy H Cancer Lett. 2024; 587:216704.

PMID: 38360138 PMC: 11257378. DOI: 10.1016/j.canlet.2024.216704.


The Versatile Attributes of MGMT: Its Repair Mechanism, Crosstalk with Other DNA Repair Pathways, and Its Role in Cancer.

Fang Q Cancers (Basel). 2024; 16(2).

PMID: 38254819 PMC: 10814553. DOI: 10.3390/cancers16020331.


Enhanced BCAT1 activity and BCAA metabolism promotes RhoC activity in cancer progression.

Qian L, Li N, Lu X, Xu M, Liu Y, Li K Nat Metab. 2023; 5(7):1159-1173.

PMID: 37337119 DOI: 10.1038/s42255-023-00818-7.


Genetically engineered mouse models for hereditary cancer syndromes.

Biswas K, Mohammed A, Sharan S, Shoemaker R Cancer Sci. 2023; 114(5):1800-1815.

PMID: 36715493 PMC: 10154891. DOI: 10.1111/cas.15737.